Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Cipla share price will remain in focus after the United States Food and Drug Administration (USFDA) has classified the ...

The USFDA has conducted routine cGMP inspection at the facility in the period between November 7 through November 13, 2024.

While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

Stocks including LIC, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry, NHPC, VA Tech Wabag and more will be in ...

VA Tech Wabag's shares soared 13.5% after the company announced winning a Rs 3,251 crore consortium order for the Al Haer ...

Cipla: The pharma player has informed the exchanges ... Brainbees Solutions: The company that runs and operates FirstCry saw its losses narrow 69.2 per cent YoY to Rs 14.7 crore in Q3FY25.

Here’s a quick look at stocks likely to be in focus in today's trade. NHPC: State-owned NHPC Ltd reported a 52.5 percent year ...

After a wild session marked by high volatility on Wednesday, the early Gift Nifty trend predicted a tranquil start for the ...

Trump's tariff news, FII selling, sanguine RBI policy, and rupee at record low dented investor sentiment today ...